Horizon Investments’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Horizon Investments's NVS Position: Q1 2026 in Review
Horizon Investments increased its Novartis (NVS) stake by 350% in Q1 2026, buying an estimated $8.58K and bringing the position to 72 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #1198.
Horizon Investments first reported a position in NVS in Q2 2017 and has held it in 17 quarters since. The position peaked at $5.78M in Q2 2020. 1,596 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Horizon Investments held 72 shares of Novartis worth $11K as of Q1 2026.
- Horizon Investments bought 56 Novartis shares in Q1 2026, an estimated $8.58K.
- Novartis made up ﹤0.01% of Horizon Investments's portfolio in Q1 2026, its #1198 holding.
- Horizon Investments first reported a position in Novartis in Q2 2017 and has held it in 17 quarters since.
- Horizon Investments's Novartis position peaked at $5.78M in Q2 2020.
- 1,596 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Horizon Investments's 13F filing for Q1 2026, filed 15 May 2026.